Fortress Biotech (NASDAQ:FBIO) reported quarterly earnings of $2.82 per share which beat the analyst consensus estimate of $(0.22) by 1381.82 percent. This is a 687.5 percent increase over losses of $(0.48) per share from the same period last year. The company reported quarterly sales of $16.038 million which missed the analyst consensus estimate of $16.338 million by 1.84 percent. This is a 22.06 percent increase over sales of $13.139 million the same period last year.